Antaros Medical is joining the war against cancer
Antaros Medical were invited to introduce its recent oncology investment at the Red Eye event “Winning the war on cancer”, September 21st. “We believe that our capabilities and experiences within the Cardio-metabolic area would be of great importance in supporting decision making and improving how to evaluate new oncology drugs”, says Johannes Hulthe, CEO Antaros Medical.
The event had 60 investors attending face-to-face and more than 1000 that followed the event live on-line. Redeye follows the technology and life science sectors for investment banking.